HOXA9 and ovarian cancer: CAFs secretes key pro-angiogenic factor VEGF-A as a result of HOXA9 upregulation from ovarian cancer cells, promoting proliferation and invasiveness of endothelial cells so as to trigger angiogenesis [32].